Compare MBI & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MBI | STXS |
|---|---|---|
| Founded | 1973 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.5M | 210.0M |
| IPO Year | 1987 | 2004 |
| Metric | MBI | STXS |
|---|---|---|
| Price | $6.90 | $2.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $8.50 | $4.00 |
| AVG Volume (30 Days) | 338.9K | ★ 390.3K |
| Earning Date | 11-04-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $93,000,000.00 | $30,075,000.00 |
| Revenue This Year | N/A | $24.21 |
| Revenue Next Year | N/A | $29.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 285.71 | 19.62 |
| 52 Week Low | $3.86 | $1.54 |
| 52 Week High | $8.26 | $3.59 |
| Indicator | MBI | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 38.38 | 43.32 |
| Support Level | $6.98 | $2.25 |
| Resistance Level | $7.20 | $2.48 |
| Average True Range (ATR) | 0.27 | 0.09 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 15.49 | 22.03 |
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.